Profil
Mr. Chris N.
Jaques is the Chief Investment Officer at Eden Financial Ltd.
He has over 18 years of experience in financial markets and has been involved in the hedge fund industry since the early 1990s, investing in hedge funds on a global basis across all styles and strategies.
He joined Eden Financial in April 2008 to manage the Eden Flagship Fund, a globally diversified, multi strategy, absolute return portfolio of hedge funds.
He is a member of the company's Asset Allocation Committee.
Prior to this, he was Head of Portfolio Management at Infiniti Capital.
Anciens postes connus de Chris N. Jaques
| Sociétés | Poste | Fin |
|---|---|---|
Eden Financial Ltd.
Eden Financial Ltd. Investment ManagersFinance EF is an active investment manager following a flexible, multi-strategy investment approach tailored to their clients' profile. They favor asset diversification and balanced portfolios. Investment decisions are based on in-depth proprietary research which pays particular attention to market trends. EF invests globally in equity, gilts and bonds, focusing on the UK. They also invest in other asset classes including emerging market securities and private or public company growth capital. In particular, they invest in private equity, pre-IPO funding, IPO operations and secondaries. EF has specialist expertise in the pharmaceutical and healthcare sectors, biotechnology and medical devices. They acquire significant stakes in innovative companies, and promote their growth. They favor companies with strong IP protection. | Directeur en chef des Investissements | 01/10/2012 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Eden Financial Ltd.
Eden Financial Ltd. Investment ManagersFinance EF is an active investment manager following a flexible, multi-strategy investment approach tailored to their clients' profile. They favor asset diversification and balanced portfolios. Investment decisions are based on in-depth proprietary research which pays particular attention to market trends. EF invests globally in equity, gilts and bonds, focusing on the UK. They also invest in other asset classes including emerging market securities and private or public company growth capital. In particular, they invest in private equity, pre-IPO funding, IPO operations and secondaries. EF has specialist expertise in the pharmaceutical and healthcare sectors, biotechnology and medical devices. They acquire significant stakes in innovative companies, and promote their growth. They favor companies with strong IP protection. | Finance |
















